Log in

Relevant bibliographies by topics / Lungs – Cancer – Gene therapy

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Lungs – Cancer – Gene therapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lungs – Cancer – Gene therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lungs – Cancer – Gene therapy"

1

Frederiksen, Klaus Stensgaard, Andreas Petri, Niels Abrahamsen, and Hans Skovgaard Poulsen. "Gene therapy for lung cancer." Lung Cancer 23, no. 3 (1999): 191–207. http://dx.doi.org/10.1016/s0169-5002(99)00012-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lara-Guerra, Humberto, and Jack A. Roth. "Gene Therapy for Lung Cancer." Critical Reviews™ in Oncogenesis 21, no. 1-2 (2016): 115–24. http://dx.doi.org/10.1615/critrevoncog.2016016084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Toloza, Eric M. "Gene Therapy for Lung Cancer." Thoracic Surgery Clinics 16, no. 4 (2006): 397–419. http://dx.doi.org/10.1016/j.thorsurg.2006.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Haura, Eric B., Eduardo Sotomayor, and Scott J. Antonia. "Gene Therapy for Lung Cancer." Molecular Biotechnology 25, no. 2 (2003): 139–48. http://dx.doi.org/10.1385/mb:25:2:139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dubinett, Steven M., Patrice W. Miller, Sherven Sharma, and Raj K. Batra. "GENE THERAPY FOR LUNG CANCER." Hematology/Oncology Clinics of North America 12, no. 3 (1998): 569–94. http://dx.doi.org/10.1016/s0889-8588(05)70009-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Toloza, Eric M., Michael A. Morse, and H. Kim Lyerly. "Gene therapy for lung cancer." Journal of Cellular Biochemistry 99, no. 1 (2006): 1–22. http://dx.doi.org/10.1002/jcb.20851.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Antonia, Scott J., and Eduardo Sotomayor. "Gene therapy for lung cancer." Current Opinion in Oncology 12, no. 2 (2000): 138–42. http://dx.doi.org/10.1097/00001622-200003000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Toloza, Eric M. "Gene Therapy for Lung Cancer." Seminars in Thoracic and Cardiovascular Surgery 17, no. 3 (2005): 205–12. http://dx.doi.org/10.1053/j.semtcvs.2005.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Woll, P. J., and I. R. Hart. "Gene therapy for lung cancer." Annals of Oncology 6 (1995): S73—S78. http://dx.doi.org/10.1093/annonc/6.suppl_1.s73.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lee, C. T., H. L. Chen, and D. P. Carbone. "Gene therapy for lung cancer." Annals of Oncology 6 (1995): S61—S63. http://dx.doi.org/10.1093/annonc/6.suppl_3.s61.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Lungs – Cancer – Gene therapy"

1

Cai, Kexia. "Gene therapy for lung cancer by adeno-associated virus-mediated expression of angiogenesis inhibitors in mouse models." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B37552661.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cai, Kexia, and 蔡克瑕. "Gene therapy for lung cancer by adeno-associated virus-mediated expression of angiogenesis inhibitors in mouse models." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B38705217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Murray, Paul Vincent. "Survival in patients with lung cancer-the roles of tumour markers and gene therapy." Thesis, King's College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.411275.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Adam, Michael R. "Does degradation of human vault RNA3 by RNA interference reduce multidrug resistance in GLC4/REV, a small-cell lung cancer cell line?" Virtual Press, 2004. http://liblink.bsu.edu/uhtbin/catkey/1306382.

Full text

Abstract:

Vaults, recently discovered in 1986, are multi-subunit organelles with a molecular mass of ,--,13 MDa. The specific function of vaults is unknown, although they are believed to be involved in internal transport. These ribonucleoproteins are composed of the major vault protein, which comprises ' 70% of the vault's mass, two minor proteins, TEP1 and vPARP, and untranslated RNA(s). It is believed that the protein components of the vault are structural while the RNAs are the functional components. Implications of the vault's involvement in multi-drug resistance in cancer have been made. In some re

APA, Harvard, Vancouver, ISO, and other styles

5

Nakaoku, Takashi. "Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma." Kyoto University, 2016. http://hdl.handle.net/2433/215443.

Full text

Abstract:

リポジトリの登録にあたっては、Peer reviewされた最終版のみ可能であり、その際には下記の出版社のウェブサイトのアドレスを記載することが求められる。当該論文は2014年6月の出版であり、12ヶ月を経過していることから、公開には差し支えはない。http://clincancerres.aacrjournals.org/content/20/12/3087.full<br>Kyoto University (京都大学)<br>0048<br>新制・課程博士<br>博士(医学)<br>甲第19617号<br>医博第4124号<br>新制||医||1015(附属図書館)<br>32653<br>京都大学大学院医学研究科医学専攻<br>(主査)教授小川誠司, 教授野田亮, 教授伊達洋至<br>学位規則第4条第1項該当

APA, Harvard, Vancouver, ISO, and other styles

6

Vasanwala, Farha Huseini. "Gene manipulations for cancer gene therapy." Diss., The University of Arizona, 2002. http://hdl.handle.net/10150/289776.

Full text

Abstract:

Tumor cells can be modified with cytokine genes such as the Interleukin-2 (IL-2) gene. The levels of IL-2 expressed are critical for successful treatment. We have tried to achieve higher levels of IL-2 than those currently available by conventional plasmids. Use of a transcriptional activator, e.g; the tat gene along with the HIV promoter driving the IL-2 gene, greatly increased IL-2 levels compared to widely used cytomegalovirus (CMV) driven plasmids. Control of the tat gene with an inducible promoter, i.e; the human HSP70B promoter, permitted control of gene expression. The inducibility of t

APA, Harvard, Vancouver, ISO, and other styles

7

Li, Yuanyuan, and 李园园. "The role of autophagy on targeted therapy in lung adenocarcinoma : in vitro and in vivo models." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2015. http://hdl.handle.net/10722/208609.

Full text

Abstract:

Non-small cell lung cancer (NSCLC) causes most of the cancer deaths worldwide. Tyrosine kinase inhibitors (TKIs), like erlotinib and crizotinib, are commonly used as specific treatments targeting epidermal growth factor receptor (EGFR)-mutated and anaplastic lymphoma kinase (ALK)-rearranged NSCLC. Autophagy is a highly conserved cellular process in response to stress. Tumor microenvironment (TME) is composed of both tumor cells and stromal cells. This study aimed to investigate whether autophagy could confer intrinsic and acquired resistance to TKIs in NSCLC, and its role in the presence of TM

APA, Harvard, Vancouver, ISO, and other styles

8

Harris, Jonathan David. "Targeted gene therapy for cancer." Thesis, Imperial College London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rigg, Anne Sagar. "Gene therapy for human cancer." Thesis, Imperial College London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341902.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pandha, Hardev Singh. "Gene transfer therapy for cancer." Thesis, Imperial College London, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.299872.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Lungs – Cancer – Gene therapy"

1

Curiel, David T., and Joanne T. Douglas, eds. Cancer Gene Therapy. Humana Press, 2005. http://dx.doi.org/10.1007/978-1-59259-785-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Habib, Nagy A., ed. Cancer Gene Therapy. Springer US, 2002. http://dx.doi.org/10.1007/b113267.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Walden, Peter. Gene therapy of cancer. Edited by European Conference on Gene Therapy of Cancer (3rd : 1997 : Berlin, Germany). Springer, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hunt, Kelly K., Stephan A. Vorburger, and Stephen G. Swisher, eds. Gene Therapy for Cancer. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-222-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Walden, Peter, Uwe Trefzer, Wolfram Sterry, Farzin Farzaneh, and Patricia Zambon, eds. Gene Therapy of Cancer. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5357-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Walther, Wolfgang, and Ulrike S. Stein, eds. Gene Therapy of Cancer. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-561-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Walther, Wolfgang, and Ulrike Stein. Gene Therapy of Cancer. Humana Press, 2000. http://dx.doi.org/10.1385/1592590861.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hansen, Heine H. Lung Cancer Therapy Annual: 2. 2nd ed. Informa Healthcare, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Roth, Jack A. Gene-based therapies for cancer. Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Chen, Ming-Jen. Combination gene therapy for colorectal cancer. University of Birmingham, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Lungs – Cancer – Gene therapy"

1

Rochlitz, C. F. "Gene Therapy for Lung Cancer." In Interventional Bronchoscopy. KARGER, 1999. http://dx.doi.org/10.1159/000062117.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Nemunaitis, John J. J. "Gene Immunotherapy for Non-Small Cell Lung Cancer." In Gene Therapy of Cancer. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-561-9_26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ujiie, Hideki, Daiyoon Lee, Tatsuya Kato, and Kazuhiro Yasufuku. "Gene Signature." In Molecular Targeted Therapy of Lung Cancer. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2002-5_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Roth, Jack A. "Gene Therapy Approaches for Lung Cancer." In Molecular Pathology Library. Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-72430-0_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Green, Nicola K., Moira G. Gilligan, David J. Kerr, Peter F. Searle, and Lawrence S. Young. "Gene Therapy for Cancer: Prospects for the Treatment of Lung Tumours." In Molecular Biology of the Lung. Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-8784-7_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gibbs, Fiona. "Gene Therapy." In Cancer and Cancer Care. SAGE Publications Ltd, 2015. http://dx.doi.org/10.4135/9781473920620.n16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Huh, Warner K., Mack N. Barnes, F. Joseph Kelly, and Ronald D. Alvarez. "Gene Therapy." In Ovarian Cancer. Springer US, 2002. http://dx.doi.org/10.1007/978-1-4757-3587-1_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Schrier, Peter I., and Susanne Osanto. "Gene Therapy." In Cancer Therapeutics. Humana Press, 1997. http://dx.doi.org/10.1007/978-1-59259-717-8_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Langer, Corey J., and Jared Weiss. "Chemotherapy for the Lungs." In Image-Guided Cancer Therapy. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-0751-6_43.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bosch, Valerie. "Gene Therapy." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_2372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lungs – Cancer – Gene therapy"

1

Wenthe, Jessica, Emma Eriksson, Ann-Charlotte Hellström, and Angelica Loskog. "Abstract B07: Immunostimulatory gene therapy enhances PD-1 blockade antibody therapy in experimental lung cancer." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 1-4, 2017; Boston, MA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/2326-6074.tumimm17-b07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Michaelsen, Signe R., Camilla L. Christensen, Maxwell Sehested, Frederik Cramer, Thomas T. Poulsen, and Hans S. Poulsen. "Abstract 832: Suicide gene therapy is effective for treating chemo-resistant small cell lung cancer cells." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-832.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lu, Charles, David J. Stewart, Lin Ji, et al. "Abstract 5391: Systemic gene therapy with tumor suppressor TUSC2/FUS1 nanoparticles for recurrent/metastatic lung cancer." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-5391.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Okon, Imoh S., Kathleen A. Coughlan, and Ming-Hui Zou. "Abstract B24: Attenuated expression of a novel mitochondrial and metabolic gene contributes to acquired gefitinib resistance in lung tumors." In Abstracts: AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy; June 18-21, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1557-3265.pms14-b24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sakai, Ryo, Kai Xu, Bingliang Fang, Jack A. Roth, and Lin Ji. "Abstract 3634: Overcoming drug resistance to EGFR-tyrosine kinase inhibitors by FUS1 or FHIT-gene therapy in human lung cancer." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3634.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Oh, JY, MY Park, SH Shim, MW Sung, and CT Lee. "Combination Gene Therapy with Conditionally Replicating Adenovirus (CRAD) and Adenovirus-Herpes Simplex Virus Thymidine Kinase (ad-HSTK) of Lung Cancer." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sonzogni, Olmo, Daniel Zak, Katy West, et al. "Abstract 1582: T-SIGn cancer gene therapy and anti-EGFR CAR-T cells synergize in combination therapy to clear A549 lung tumor xenografts and lung metastases in NSG mice." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1582.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Rauthan, Amit, Poonam Patil, Rajashree Aswath, Nitin Yashas, and Gaurav Ningade. "Immunotherapy in Patients with Lung Cancer with Driver Mutations: A Single-Centre Experience." In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735365.

Full text

Abstract:

Abstract Introduction Immunotherapy has revolutionized treatment in metastatic nonsmall cell lung cancer (NSCLC) without driver mutations. Trial data shows that programmed death-1/PDL1 blockade in epidermal growth factor receptor (EGFR) and other driver mutation positive lung cancers is not beneficial; and instead maybe detrimental. Here, we evaluated the efficacy of immune check point inhibitors in a series of patients with EGFR and other driver mutation–positive advanced NSCLC. Objectives This study was aimed to evaluate the efficacy of immune check point inhibitors in a series of patients w

APA, Harvard, Vancouver, ISO, and other styles

9

Zarogoulidis, Paul, Wolfgang Hohenforst-Schmidt, Kaid Darwiche, et al. "Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Noureddine, Moataz, Katy West, Elizabeth Isaacson, et al. "Abstract 1710: A T-SIGn cancer gene therapy virus expressing an EpCAM-targeted bispecific T-cell activator stimulates T-cells and induces tumor cell death in patient-derived organotypic non-small cell lung cancer (NSCLC) spheroidsex vivo." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1710.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lungs – Cancer – Gene therapy"

1

Pitha-Rowe, Paula Marie. Ribozyme-Mediated Breast Cancer Gene Therapy. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada394199.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

DeWeese, Theodore L. Oncolytic Gene Therapy for Prostate Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada401492.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nesbit, Heike K. Gene Therapy Mediated Breast Cancer Immunity. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada382694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ye, Xiang-Cang, and Bert W. O'Malley. Regulatable Gene Therapy for Prostate Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada413579.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pitha-Rowe, Paula M., Lesia Dropulic, and Boro Dropulic. Ribozyme-Mediated Breast Cancer Gene Therapy. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407229.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ponnazhagan, Selvarangan. Targeted Gene Therapy for Breast Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada427915.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Baker, Laurence H. Gene Therapy of Human Breast Cancer. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada372212.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Eck, Stephen, and Heike Boxhorn. Gene Therapy Mediated Breast Cancer Immunity. Defense Technical Information Center, 1997. http://dx.doi.org/10.21236/ada335064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ding, Yi. Adenovirus-Mediated p202 Gene Transfer in Breast Cancer Gene Therapy. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada442740.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ponnazhagan, Selvarangan. Anti-Angiogenic Gene Therapy for Prostate Cancer. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada443094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!